Dermira Takes Rights to Roche’s Dermatitis Drug

16.08.2017 - US biotech Dermira has agreed to license certain rights from Swiss drugmaker Roche and its subsidiary Genentech for the investigational atopic dermatitis drug, lebrikizumab. The...